| 摘要 |
The present invention relates to new polynucleotides deriving from the nucleotide sequence of the GCP-2 gene and comprising new SNPs, new polypeptides derived from the natural protein GCP-2 and comprising a mutation caused by the SNPs of the invention as well as their therapeutic uses. |
